ProCE Banner Series

Equitable Education: Strategies for NPs and PAs to Reduce Healthcare Disparities in Underserved and Underrepresented Patients With Moderate to Severe Atopic Dermatitis

Despite a rapid expansion of systemic options to manage moderate to severe atopic dermatitis recently approved or in late-stage development, disparities in care remain. Join a live, roundtable webinar to learn practical strategies to address healthcare disparities to ensure equitable AD care for underserved and underrepresented communities.

  AAPA
  | ANCC
Who Should Attend

This program is intended for nurse practitioners and physician associates who care for underserved/underrepresented patients with moderate to severe atopic dermatitis.

All Events

Equitable Education: Strategies for NPs and PAs to Reduce Healthcare Disparities in Underserved and Underrepresented Patients With Moderate to Severe Atopic Dermatitis

Past Events

September

24

2024

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

October

01

2024

7:00 PM - 8:00 PM Eastern Time (ET)

Virtual

October

08

2024

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Terry Faleye, MPAS, PA-C

Dermsurgery Associates – Kingwood
Houston, Texas

ProCE Banner Faculty
Victoria Garcia-Albea, PNP, DCNP

Director, Lahey Dermatology Nurse Practitioner Training Program
Lahey Dermatology
Burlington, Massachusetts

ProCE Banner Faculty
Peter Lio, MD, FAAD

Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Founding Director, Chicago Integrative Eczema Center
Founding Partner, Medical Dermatology Associates of Chicago
Chicago, Illinois

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Atopic Dermatitis.

Target Audience
This program is intended for nurse practitioners and physician associates who care for underserved/underrepresented patients with moderate to severe atopic dermatitis. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate effective strategies for diagnosing moderate to severe atopic dermatitis in patients with skin of color through physical examination and a thorough medical history
  • Implement strategies that are aimed at providing optimal management of moderate to severe atopic dermatitis to patients affected by healthcare disparities in underrepresented and underserved populations
  • Evaluate strategies for addressing patient-level and practice-level disparities in care among patients with moderate to severe atopic dermatitis

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE).

Supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.